A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to < 9 Years
Набор не начат
- Терапия: bioCSL Trivalent Influenza Virus Vaccine (CSL TIV); Comparator Quadrivalent Influenza Virus Vaccine